TrialBMC cancer2018

Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: a prospective, longitudinal, single center study.

Lu Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.